Journal of Jilin University(Medicine Edition) ›› 2025, Vol. 51 ›› Issue (5): 1260-1266.doi: 10.13481/j.1671-587X.20250512

• Research in basic medicine • Previous Articles    

Preparation of nanodrug PTX2 NPs and its killing effect on human lung cancer A549 cells

Han XUE1,Yuxin FAN1,Ting ZHANG2,Zhimin LI1,Mingge HUO1,Xingang GUAN1,3()   

  1. 1.Department of Clinical Laboratory Diagnostics,School of Medical Technology,Beihua University,Jilin 132013,China
    2.Department of Respiratory Medicine,First People’s Hospital,Wenling City,Zhejiang Province,Taizhou 317599,China
    3.Department of Basic Medicine,School of Medical Sciences,Taizhou College,Taizhou 318000,China
  • Received:2024-10-19 Accepted:2024-12-05 Online:2025-09-28 Published:2025-11-05
  • Contact: Xingang GUAN E-mail:guanxg@ciac.ac.cn

Abstract:

Objective To prepare the nanodrug paclitaxel dimer(PTX2)-loaded nanoparticles(NPs) using the block copolymer 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol 2000,(DSPE-PEG2000), and to explore the killing effect of PTX2 NPs on the human lung cancer A549 cells and its influence on apoptotis. Methods The PTX2 NPs were prepared using nanoprecipitation method. Dynamic light scattering (DLS) was employed to determine the particle size distribution, and transmission electron microscope (TEM) was used to observe the ultrastructure of the nanoparticles. After treatment of 0 and 10 mmol·L-1 dithiothreitol (DTT), dialysis method was used to evaluate the in vitro drug release profile of PTX2 NPs. The cell counting kit-8(CCK-8) method was used to assess the survival rates of the A549 cells after treated with PTX2 and PTX2 NPs with different concentrations (0.000 1, 0.001 0, 0.010 0, 0.100 0, and 1.000 0 μmol·L-1). The A549 cells were divided into control group, PTX2 group, and PTX2 NPs group.Live/dead staining method was used to detect the survival of the A549 cells in various groups, and flow cytometry was used to detect the apoptotic rates of the A549 cells in various groups. Results The mean hydrodynamic diameter of PTX2 NPs was determined to be 144.7 nm by DLS. The TEM imaging confirmed uniform spherical morphology of PTX2 NPs. In a reductive environment, the PTX2 NPs exhibited continuous drug release with total paclitaxel(PTX) release of 84% within 72 h. The results of CCK-8 method showed that both PTX2 and PTX2 NPs inhibited the proliferation of A549 cells in a dose-dependent manner. When the concentrations of PTX<0.01 μmol·L-1, compared with PTX2 group,the survival rates of A549 cells in PTX2 NPs group were significantly decreased (P<0.01 or P<0.001). The live/dead staining results showed that compared with PTX2 group,the number of red fluorescence-labeled dead cells in PTX2 NPs group was increased. The flow cytometry results demonstrated that compared with control group and PTX2 group,the apoptotic rates of the A549 cells in PTX2 NPs group were significantly increased (P<0.05 or P<0.01). Conclusion The PTX2-loaded nanoparticles PTX2 NPs are successfully prepared which exhibits responsive drug release and demonstrates a more significant killing effect on the human lung cancer A549 cells compared to PTX2.

Key words: Paclitaxel dimer, Nanoparticle, Lung adenocarcinoma, Drug delivery, Apoptosis

CLC Number: 

  • R730.53